ZVIA vs. REED, KOF, FMX, MNST, CCEP, CELH, COKE, FIZZ, PRMW, and FHTX
Should you be buying Zevia PBC stock or one of its competitors? The main competitors of Zevia PBC include Reed's (REED), Coca-Cola FEMSA (KOF), Fomento Económico Mexicano (FMX), Monster Beverage (MNST), Coca-Cola Europacific Partners (CCEP), Celsius (CELH), Coca-Cola Consolidated (COKE), National Beverage (FIZZ), Primo Water (PRMW), and Foghorn Therapeutics (FHTX).
Zevia PBC (NYSE:ZVIA) and Reed's (NYSE:REED) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk.
Zevia PBC has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, Reed's has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.
Reed's has lower revenue, but higher earnings than Zevia PBC. Zevia PBC is trading at a lower price-to-earnings ratio than Reed's, indicating that it is currently the more affordable of the two stocks.
In the previous week, Zevia PBC had 2 more articles in the media than Reed's. MarketBeat recorded 3 mentions for Zevia PBC and 1 mentions for Reed's. Zevia PBC's average media sentiment score of 0.45 beat Reed's' score of 0.00 indicating that Zevia PBC is being referred to more favorably in the media.
Zevia PBC received 14 more outperform votes than Reed's when rated by MarketBeat users. Likewise, 31.91% of users gave Zevia PBC an outperform vote while only 1.52% of users gave Reed's an outperform vote.
53.2% of Zevia PBC shares are owned by institutional investors. Comparatively, 51.5% of Reed's shares are owned by institutional investors. 12.6% of Zevia PBC shares are owned by insiders. Comparatively, 46.7% of Reed's shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Zevia PBC has a net margin of -15.58% compared to Reed's' net margin of -29.75%. Reed's' return on equity of 0.00% beat Zevia PBC's return on equity.
Zevia PBC currently has a consensus target price of $3.21, indicating a potential upside of 262.24%. Reed's has a consensus target price of $7.00, indicating a potential upside of 384.43%. Given Reed's' stronger consensus rating and higher possible upside, analysts plainly believe Reed's is more favorable than Zevia PBC.
Summary
Zevia PBC beats Reed's on 11 of the 18 factors compared between the two stocks.
Get Zevia PBC News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZVIA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZVIA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zevia PBC Competitors List
Related Companies and Tools
